Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
22 December, 2014 10:51 IST
Astrazeneca Pharma turns to loss in Q3
Source: IRIS | 06 Feb, 2013, 05.31PM
Comments  |  Post Comment

Astrazeneca Pharma India, an integrated biopharmaceutical company, posted net loss of Rs 176.95 million for the quarter ended Dec. 31, 2012 as compared to net profit of Rs 149.37 million for the same period in the previous year.

Net sales has decreased 31.65% to Rs 1.05 billion for the quarter ended Dec 31, 2012 from Rs 1.54 billion for the same period in the previous year.

Shares of AstraZeneca declined Rs 2.65, or 0.2%, to settle at Rs 1,323.65. The total volume of shares traded was 2,529 at the BSE (Wednesday).

Astrazeneca Pharma India Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Security Code type    into this box
Related Articles
McNally Bharat bags order worth Rs 1.17 bn - 22-Dec-2014 10:33
CG powers 250,000 households in Europe, reducing CO2 emissions by 255,000 tons - 22-Dec-2014 10:20
SBI launches tech learning centres for customers - 22-Dec-2014 10:14
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer